Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

However, for Q1 2025, Centene Corporation (NYSE:CNC) stated that premium and service revenues rose by 17% to $42.5 billion ...

Fintel reports that on July 16, 2025, B of A Securities downgraded their outlook for Centene (NYSE:CNC) from Neutral to ...

Centene (CNC) stock and HCA Healthcare (HCA) stock are downgraded at Bank of America based on risks from Trump’s One Big Beautiful Bill Act. Read more here.

Centene fell by 11.1 percent week-on-week, from $31.44 on July 11 to $27.95 last Friday—a new all-time low, as investors turned cautious ahead of its second quarter earnings results, further ...

Investing.com - JPMorgan downgraded Centene (NYSE:CNC), a $28.19 billion healthcare provider trading at 8.46x earnings, from Overweight to Neutral on Tuesday, slashing its price target to $48.00 ...

Meanwhile, Barclays downgraded Centene from Overweight to Equalweight, expressing concerns about the Part D and ACA segments and adjusting their earnings per share estimates downward for 2025 and ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Fintel reports that on July 2, 2025, UBS downgraded their outlook for Centene (NYSE:CNC) from Buy to Neutral. Analyst Price Forecast Suggests 36.47% Upside As of June 20, 2025, the average one ...

Analysts have provided mixed ratings on Centene’s stock. Cantor Fitzgerald reiterated an Overweight rating with a $90 price target, citing limited impact from tightened Medicaid work requirements.

Investing.com -- Shares of Centene (NYSE: CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in the ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in the ...